The briefing
Researchers presented newly developed biomarkers that may improve detection and treatment of neurological and psychiatric conditions, including Alzheimer’s disease and mood disorders. The findings were unveiled at Neuroscience 2026, the Society for Neuroscience’s annual meeting.
Original headline
New biomarkers for Alzheimer's disease, depression and beyond